Previous Close | 203.40 |
Open | 198.95 |
Bid | 197.35 x 20000 |
Ask | 201.40 x 20000 |
Day's Range | 198.95 - 203.80 |
52 Week Range | 126.40 - 218.20 |
Volume | |
Avg. Volume | 25 |
Market Cap | 29.94B |
Beta (5Y Monthly) | 0.67 |
PE Ratio (TTM) | 32.98 |
EPS (TTM) | N/A |
Earnings Date | N/A |
Forward Dividend & Yield | 1.79 (0.90%) |
Ex-Dividend Date | May 08, 2024 |
1y Target Est | N/A |
Hologic's (HOLX) GYN Surgical Q2 performance was driven by strong results from MyoSure and Fluent Fluid Management.
Lantheus' (LNTH) robust revenues from the majority of its segments drive its first-quarter performance.
Bruker's (BRKR) BioSpin segment witnessed growth across biopharma, academic government and industrial research in the first quarter of 2024.